Cargando…
Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages
Tumor-associated macrophages (TAMs) are key components of the tumor microenvironment in non-medullary thyroid cancer (TC), the most common endocrine malignancy. However, little is known regarding the regulation of their function in TC. Transcriptome analysis in a model of TC-induced macrophages iden...
Autores principales: | Arts, Rob J. W., Plantinga, Theo S., Tuit, Sander, Ulas, Thomas, Heinhuis, Bas, Tesselaar, Marika, Sloot, Yvette, Adema, Gosse J., Joosten, Leo A. B., Smit, Johannes W. A., Netea, Mihai G., Schultze, Joachim L., Netea-Maier, Romana T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213309/ https://www.ncbi.nlm.nih.gov/pubmed/28123869 http://dx.doi.org/10.1080/2162402X.2016.1229725 |
Ejemplares similares
-
Role of Genetic Variants of Autophagy Genes in Susceptibility for Non-Medullary Thyroid Cancer and Patients Outcome
por: Plantinga, Theo S., et al.
Publicado: (2014) -
Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer
por: Plantinga, Theo S., et al.
Publicado: (2016) -
Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma
por: Rabold, Katrin, et al.
Publicado: (2022) -
Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics
por: Rabold, Katrin, et al.
Publicado: (2020) -
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non‐medullary thyroid cancer
por: Crezee, Thomas, et al.
Publicado: (2021)